**Author details**

Vinayak Uppin, Pooja Acharya and Ramaprasad Ravichandra Talahalli\* Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, Karnataka, India

\*Address all correspondence to: ramaprasad@cftri.res.in

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**207**

*Modulatory Potentials of n-3 Polyunsaturated Fatty Acids in Inflammatory Diseases*

[10] Gerasimidis K et al. Dietary

modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2008;**27**(2):155-165

[11] Wall R et al. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutrition Reviews. 2010;**68**(5):280-289

[12] Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine. 2008;**233**(6):674-688

[13] Simopoulos AP. Omega-6/omega-3 essential fatty acids: Biological effects. World Review of Nutrition and Dietetics. 2009;**99**(1):1-16

[14] Simopoulos AP. Importance of the omega-6/omega-3 balance in health and disease: Evolutionary aspects of diet. In: Healthy Agriculture, Healthy Nutrition,

Healthy People. Vol. 102. Karger Publishers; 2011. pp. 10-21

polyunsaturated fatty acids improve cognitive function and prevent

depression, dementia, and Alzheimer's

[16] Yang X et al. Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing. Neurochemistry International.

[17] Endres S et al. n-3 polyunsaturated fatty acids: Update 1995. European Journal of Clinical Investigation.

[18] Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for

[15] Das UN. Folic acid and

disease—But how and why? Prostaglandins, Leukotrienes and Essential Fatty Acids. 2008;**78**(1):11-19

2011;**58**(3):321-329

1995;**25**(9):629-638

*DOI: http://dx.doi.org/10.5772/intechopen.88394*

[1] Saetta M et al. Airway eosinophilia

[2] Dartt DA et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation.

in chronic bronchitis during exacerbations. American Journal of Respiratory and Critical Care Medicine.

The Journal of Immunology. 2011;**186**(7):4455-4466

Thorax. 1999;**54**(3):245-252

[3] Barnes PJ. Molecular genetics of chronic obstructive pulmonary disease.

[4] Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;**86**(3):453-460

[5] Ryder SD, Beckingham IJ. Acute hepatitis. BMJ. 2001;**322**(7279):151-153

[6] Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. Journal of Allergy and Clinical Immunology.

[7] Centers for Disease Control and Prevention (CDC). Arthritis: Disabilities and Limitations. Retrieved from: https://www.cdc.gov/arthritis/ data\_statistics/arthritis-disabilities-

[8] Skoner DP. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. Journal of Allergy and Clinical Immunology.

[9] Maroon JC, Bost JW. ω-3 fatty acids (fish oil) as an anti-inflammatory: An alternative to nonsteroidal antiinflammatory drugs for discogenic pain. Surgical Neurology. 2006;**65**(4):326-331

2017;**140**(3):645-653

limitations-tables.htm

2001;**108**(1):S2-S8

1994;**150**(6):1646-1652

**References**

*Modulatory Potentials of n-3 Polyunsaturated Fatty Acids in Inflammatory Diseases DOI: http://dx.doi.org/10.5772/intechopen.88394*
